Trial Profile
A phase I study investigating AAT-009 [RQ-9] for the treatment of Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs ATT 09 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 16 Mar 2016 New trial record